Disease-Modifying Effects of Vincamine Supplementation in Drosophila and Human Cell Models of Parkinson's Disease Based on DJ-1 Deficiency.
Researchers found that a natural compound called vincamine showed promise in treating Parkinson's disease by improving motor ability in a fly model and reducing oxidative stress-induced death in human cells. Vincamine was shown to suppress PD-related symptoms and increased mitochondrial viability while decreasing apoptosis in human cells. The study also suggested that targeting voltage-gated sodium channels may be a promising avenue for treating PD.
- Sanz FJ, Solana-Manrique C and Paricio N (2023).
- ACS Chem Neurosci.
- PubMed:
- 37289979